Journal for ImmunoTherapy of Cancer (Nov 2021)
657 Characterization and therapeutic targeting of a tumor-associated tolerogenic DC subpopulation driven by SREBP2 and the mevalonate metabolic pathway
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)